The ATCR Meeting brings together scientists, clinicians, and industry leaders to explore the latest in T-cell research, with a focus on high-throughput sequencing technologies. These powerful tools have become essential for uncovering new insights into the human immune system, particularly the pivotal role of T-cells in infectious diseases, vaccine development, cancer, and autoimmune disorders.
Building on the success of previous editions—100 attendees in 2018, 80 in 2019, and 140 in 2023—the 2025 meeting promises to be a key gathering for the T-cell research community. This year’s event will also celebrate a major milestone: 10 years of the AUDACIS consortium in the Antwerp region.
All details are available on the conference page.